ONCY Oncolytics Biotech Inc.
Fundamentals / CIK 0001129928 / USDOncolytics Biotech Inc. reported $5.83M in total assets and a net loss of $37.28M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ONCY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$37.89M Operating profit
-
Net Income FY 2025-$37.28M GAAP bottom line
-
Diluted EPS FY 2025-$0.29 Split-adjusted
-
Free Cash Flow FY 2025-$28.79M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$2.43M Total debt: $410K
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Research & Development | $13.31M | $15.44M |
| Total Operating Expenses | $28.73M | $25.54M |
| Operating Income | -$28.73M | -$25.54M |
| EBITDA | -$28.66M | -$25.45M |
| Interest Income | $386K | $975K |
| Income Before Tax | -$28.68M | -$22.70M |
| Income Tax Expense | $79K | $95K |
| Net Income | -$28.76M | -$22.79M |
| Basic EPS | -$0.30 | -$0.30 |
| Diluted EPS | -$0.30 | -$0.30 |
| Basic Shares Outstanding | 95.9M | 76.5M |
| Diluted Shares Outstanding | 95.9M | 76.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $5.15M | $4.26M | $4.55M | $3.52M | $5.08M | $1.92M | $2.80M |
| Total Operating Expenses | $9.74M | $9.38M | $9.28M | $9.49M | $9.56M | $4.65M | $5.02M |
| Operating Income | -$9.74M | -$9.38M | -$9.28M | -$9.49M | -$9.56M | -$4.65M | -$5.02M |
| EBITDA | -$9.72M | -$9.36M | -$9.27M | -$9.47M | -$9.55M | -$4.63M | -$5.00M |
| Interest Income | $19K | $37K | $44K | $74K | $95K | $100K | $117K |
| Income Before Tax | -$9.72M | -$9.34M | -- | -- | -$10.06M | -$5.22M | -- |
| Income Tax Expense | -$13K | $101K | -- | -- | -$181K | $61K | -- |
| Net Income | -$9.71M | -$9.44M | -$9.24M | -$8.89M | -$9.88M | -$5.28M | -$4.71M |
| Basic EPS | -$0.08 | -$0.08 | -$0.08 | -- | -$0.10 | -$0.06 | -$0.06 |
| Diluted EPS | -$0.08 | -$0.08 | -$0.08 | -- | -$0.10 | -$0.06 | -$0.06 |
| Basic Shares Outstanding | 127.9M | 119.7M | 112.3M | -- | 101.3M | 91.0M | 84.6M |
| Diluted Shares Outstanding | 127.9M | 119.7M | 112.3M | -- | 101.3M | 91.0M | 84.6M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $5.20M | $11.08M |
| Cash & Short-Term Investments | $5.20M | $11.08M |
| Total Current Assets | $6.84M | $12.44M |
| Property, Plant & Equipment, Net | $228K | $286K |
| Total Non-Current Assets | $738K | $985K |
| Total Assets | $7.58M | $13.42M |
| Accounts Payable | $3.50M | $756K |
| Other Current Liabilities | $0 | $1.12M |
| Total Current Liabilities | $6.10M | $4.88M |
| Deferred Revenue (Non-Current) | $4.91M | $4.68M |
| Total Non-Current Liabilities | $5.28M | $5.24M |
| Total Liabilities | $11.38M | $10.12M |
| Total Debt (incl. Leases) | $563K | $761K |
| Common Stock | $0 | $0 |
| Retained Earnings | -$429.5M | -$400.7M |
| Accumulated Other Comp. Income | $6.22M | $6.36M |
| Total Stockholders' Equity | -$3.80M | $3.30M |
| Total Equity | -$3.80M | $3.30M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $2.43M | $4.12M | $5.49M | $5.20M | $11.08M |
| Cash & Short-Term Investments | $2.43M | $4.12M | $5.49M | $5.20M | $11.08M |
| Total Current Assets | $5.27M | $7.07M | $7.49M | $6.84M | $12.44M |
| Property, Plant & Equipment, Net | $193K | $202K | $218K | $228K | $286K |
| Total Non-Current Assets | $558K | $602K | $674K | $738K | $985K |
| Total Assets | $5.83M | $7.67M | $8.16M | $7.58M | $13.42M |
| Accounts Payable | $3.21M | $3.40M | $2.68M | $3.50M | $756K |
| Other Current Liabilities | -- | -- | -- | $0 | $1.12M |
| Total Current Liabilities | $5.92M | $5.22M | $5.42M | $6.10M | $4.88M |
| Deferred Revenue (Non-Current) | $4.91M | $4.91M | $4.91M | $4.91M | $4.68M |
| Total Non-Current Liabilities | $7.42M | $8.61M | $7.87M | $5.28M | $5.24M |
| Total Liabilities | $13.34M | $13.84M | $13.29M | $11.38M | $10.12M |
| Total Debt (incl. Leases) | $410K | $448K | $508K | $563K | $761K |
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$457.9M | -$448.2M | -$438.7M | -$429.5M | -$400.7M |
| Accumulated Other Comp. Income | $6.22M | $6.22M | $6.22M | $6.22M | $6.36M |
| Total Stockholders' Equity | -$7.50M | -$6.17M | -$5.13M | -$3.80M | $3.30M |
| Total Equity | -$7.50M | -$6.17M | -$5.13M | -$3.80M | $3.30M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$28.76M | -$22.79M |
| Depreciation & Amortization | $70K | $87K |
| Stock-Based Compensation | $3.10M | $1.98M |
| Change in Payables | $2.93M | $4.0K |
| Operating Cash Flow | -$20.11M | -$19.88M |
| Capital Expenditure | -$6.0K | -$174K |
| Free Cash Flow | -$20.12M | -$20.06M |
| Investing Cash Flow | -$6.0K | -$174K |
| Financing Cash Flow | $14.12M | $5.03M |
| Net Change in Cash | -$5.88M | -$15.32M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$9.71M | -$9.44M | -$9.24M | -$8.89M | -$9.88M | -$5.28M | -$4.71M |
| Depreciation & Amortization | $17K | $15K | $16K | $16K | $17K | $18K | $19K |
| Stock-Based Compensation | $1.29M | $1.79M | $2.30M | $985K | $912K | $362K | $845K |
| Change in Payables | -$190K | $730K | -$813K | $1.22M | $1.36M | $242K | $112K |
| Operating Cash Flow | -$6.92M | -$8.14M | -$7.29M | -$6.43M | -$4.84M | -$4.11M | -$4.73M |
| Capital Expenditure | -$7.0K | $0 | -$6.0K | -$1.0K | -$4.0K | $0 | -$1.0K |
| Free Cash Flow | -$6.92M | -$8.14M | -$7.30M | -$6.43M | -$4.85M | -$4.11M | -$4.73M |
| Investing Cash Flow | -$7.0K | $0 | -$6.0K | -$1.0K | -$4.0K | $0 | -$1.0K |
| Common Stock Issued | -- | -- | $7.61M | -- | -- | -- | $4.18M |
| Financing Cash Flow | $5.24M | $6.77M | $7.61M | $2.75M | $3.09M | $4.09M | $4.18M |
| Net Change in Cash | -$1.69M | -$1.38M | $291K | -$3.67M | -$1.85M | $76K | -$434K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Equity (ROE) | -- | -691.1% |
| Return on Assets (ROA) | -379.3% | -169.8% |
| Current Ratio | 1.12x | 2.55x |
| Quick Ratio | 0.85x | 2.27x |
| Debt to Equity | -- | 0.23x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -639.3% | -488.3% | -407.9% | -379.3% | -- | -- | -- |
| Current Ratio | 0.89x | 1.35x | 1.38x | 1.12x | -- | -- | -- |
| Quick Ratio | 0.41x | 0.79x | 1.01x | 0.85x | -- | -- | -- |